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ABSTRACT 
Dengue is one of the common mosquito-borne arbovirus infections, especially in India. Dengue virus is a single strand RNA virus, which composed 
of four serotypes and these serotypes, belongs to the flavivirus genus. Dengue viruses are normally transmitted through the bites of aedes mosquito 
species. Dengue is the most frequent cause of fever which is caused with thrombocytopenia. Dengue is probably a fatal ailment that is widely spread 
through the tropical and subtropical regions of the world affecting urban and semi-urban areas. It also becomes a dominant health concern globally 
in recent decades. The most serious complications of this infection are dengue haemorrhagic fever and dengue shock syndrome. 18 y old male 
patient was admitted to the general ward in thiruvallur government hospital with chief complaints of fever, vomiting and dehydration, cough with 
expectorant for a period of 3 d. The patient was diagnosed with dengue fever followed by thrombocytopenia and advised for proper rehydration 
therapy. The patient was initiated with prophylactic therapy and Oral Rehydration Solution. He was also treated by focusing points based on patient 
counselling to recover the current condition. The patient was counseled accordingly as regular sit-ups, with points focusing on disease condition 
and therapy prescribed. The current case was aimed to target on the counselling points for dengue, which made a better improvement in the patient 
with severe dengue fever with thrombocytopenia and this could be a measure as community awareness outlook to spread alertness which can avoid 
the outbreak of Dengue.  
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Dengue is a mosquito-borne viral infection, which spreads rapidly 
[1, 2]. It is caused by 4 serotypes DENV–dengue virus (DENV1, 
DENV2, DENV3, and DENV4) Dengue fever, dengue hemorrhagic 
fever, and dengue shock syndrome; which is one among the lethal 
illness [3]. This disease leads from a relatively minor febrile illness 
to a life-threatening condition. Infection is the most common cause 
of thrombocytopenia. Thrombocytopenia associated with fever 
helps to narrow the differential diagnosis and management of fever 
[4]. It also helps to know the various complications of thrombo-
cytopenia and its management. The aedes aegypti mosquitos are the 
one, which spreads the lethal illness named dengue and dengue 
viruses are also called as arboviruses [5]. These mosquito breeds in 
water holding receptacles such as desert coolers, vases, discarded 
containers, coconut husks, or old tires or in plants close to human 
dwellings. The accumulation of infection is both man and mosquito 
[6]. 70% of the 96 million apparent infections occur in Asia, in which 
India is making up to one-third of the total. In spite of abundant 
efforts to control the mosquito populations, dengue fever has arisen, 
extend and established itself vastly. The most serious complication 
of the infection is Dengue Hemorrhagic Fever (DHF) and Dengue 
Shock Syndrome (DSS). Individuals of all ages and both sexes are 
susceptible to dengue fever [7]. It is accompanied by high fever, 
headache, dehydration, anorexia, muscle and joint pain, etc. Some 
patients also have a macular rash, lymphadenopathy, and palatal 
vesicles. Epistaxis and scattered petechiae are commonly seen in 
uncomplicated dengue. Preexisting gastrointestinal lesions may 
bleed during the acute illness [8, 9]. It can be treated with 
antibiotics, painkillers and oral fluids. Each year between 50 and 
528 million people are infected, and fatality reports were 
approximately 10,000 to 20,000 are reported due to lack of a simple 
tool to differentiate mild life-threatening infection. This may lead to 
unnecessary hospitalization to dengue patients [10]. 
CASE REPORT 
18 y old male patient was admitted in the male general male ward in 
Thiruvallur government hospital with chief complaints of fever, 
vomiting, and dehydration for 3 d and cough with expectorant for a 
period of 3 d. On general examination, the patient was conscious, 
oriented, and febrile. On examination, patient Blood pressure was 
found deceased. The abdomen evaluation revealed that per 
abdomen was soft, and other observed parameters are normal. 
 
Table 1: Symptoms of dengue 
S. No. Symptoms Patient condition 
1. Loose stools - 
2. Fever + 
3. Vomiting + 
4. Melena  - 
5. Dehydration + 
6. Abdominal Pain - 
7. Muscle and joint pain + 
8. A cough with expectorant + 
9. Headache  + 
*+and-denotes positive and negative of symptoms with accordance with particular symptoms of Dengue.  
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Table 2: Laboratorical investigations from the day of admission 
S. 
No. 
















1. White blood count (WBC) 103/µl 4800 3800 3500 2900 2900 4100 3100 5600 
2. Red blood count (RBC) 106/µl 4.79 3.86 4.56 4.37 - - 3.76 - 
3. Haematocrit (HCT) % 41.2 34.6 39.3 38.3 - - 36.8 - 
4. Haemoglobin (HB)  g/dL 13 11.5 13.9 13.5 12.6 15.3 12.6 15.8 
5. Mean corpuscular volume 
(MCV) 
fL 86.0 89.6 86.2 87.6 - - 85.3 - 
6. Mean cell haemoglobin 
(MCH) 
Pg 30.5 29.8 30.5 30.9 - - 28.7 - 
7. Mean cell haemoglobin 
concentration (MCHC) 
g/dL 35.4 33.2 35.4 35.2 - - 34.5 - 
8. Platelets (PLT) 103/µl 80000 79000 78000 71000 69000 67000 50000 46000 
9. Lymphocyte 103/µl 0.9 0.6 0.6 0.8 - - 0.6 - 
10. Lymphocyte % % 30.7 14.5 18.4 27.6 - - 14.7 - 
11. RDW–SD fL 45.1 46.5 45.9 45.7 - - 44.1 - 
12. RDW–CV % 13.6 13.3 13.8 13.4 - - 13.2 - 
13. Platelet distribution width 
(PDW) 
fL 13.1 11.7 14.5 17.0 - - 11.8 - 
14. Mean platelet volume 
(MPV) 
fL 11.1 10.6 11.0 12.7 - - 10.4 - 
15. Platelet large cell ratio 
(PCR) 
% 32.1 28.1 34.5 +45.2 - - 38.2 - 
16. Procalcitonin % -0.10 -0.11 -0.11 -0.12 - - -0.11 - 
17. Packed cell volume (PCV) % 38.6 34.6 39.3 38.3 37.7 43 31 44 
18. Mixed cell count 103/µl 0.4 0.2 0.3 - - - - - 
19. Mixed cell count% % 10.6 5.2 9.2 - - - - - 
20. Neutrophil count 103/µl 2.3 3.0 2.6 - - - - - 
21. Neutrophil count% % 58.7 80.3 72.4 - - - - - 
*Day of admission, RDW-SD represents Red blood cell Distribution Width of actual size, RDW–CV represents Red blood cell Distribution Width of 
cell volume, pg represents picograms, fL represents femtolitres, µl represents microliters, dL represents decilitres, g represents grams. 
 
 
Fig. 1: Volume replacement algorithm for patients with moderate dengue fever (DHF grade I, II & III), ABCS = Acidosis, Bleeding, Calcium 
(Na++and K+), Sugar, SBP–systolic blood pressure, IV-Intravenous, *Improvement: Hct falls, pulse rate and Blood pressure stable, Urine 
output rises, **No improvement: Hct or pulse rate rises, pulse pressure falls below: 20 mmhg, urine output falls 
Jeyamani et al. 




Fig. 2: Volume replacement algorithm for patients with severe dengue fever [DHF IV (DSS)] 
 
DISCUSSION 
The patient was observed with a low platelet count, low white blood 
count, packed cell volume and Mean cell haemoglobin concentration at 
the time of admission. The patient haematology and biochemical 
parameters were observed at regular intervals. The serological findings 
such as Immunoglobulin M and Immunoglobulin G were found positive, 
which indicated the presence of Dengue. The patient was diagnosed with 
dengue fever and advised for proper rehydration therapy. The patient 
was treated with Injection Cefotaxime 1g twice a day, Injection 
Ranitidine 2CC twice a day, Injection Paracetamol twice a day if 
necessary, Tabet Chlorpheniramine 4 mg twice a day, Tabet Vitamin B 
Complex, Tab. Paracetamol, Tab. Rantac, Platelet oral fluids and Oral 
Rehydration Solution as prophylactic therapy.  
The patient was counselled accordingly as regular sit-ups, with 
points focusing disease condition, therapy prescribed. The patient 
counselling points include lifestyle changes along with dietary 
restrictions.  
• Avoid mosquito bites when traveling in tropical areas by using 
powerful plug-in mosquito repellent, even indoors as aedes is day 
bitting mosquito. 
• Breeding of vector mosquitoes can be reduced by eliminating 
small accumulations of stagnant water around human habitats.  
• Eliminating mosquito breeding sites in these areas is another key 
prevention measure. Stay away from old tires, cans, or flower pots 
that collect rain. Coolers and tanks must regularly be cleaned and 
kerosene oil added to their water. Because these are the ideal places 
for mosquitoes to breed. 
• It is a safer bet to use mosquito nets while sleeping, which was a 
common practice. Mosquito bats are also advisable. 
• Oral fluids should be encoursed to drink throughout the day, oral 
dehydration solution, fruit juice to prevent dehydration from fever, lack 
of oral intake or vomiting. Drinking fresh Vitamin C juice will boost up 
the digestion as well as it will promote the antibodies for a rapid 
recovery.  
• Drink plenty of water to flush out the toxins from the body, which 
excreted in the form of urine. 
• Patients are advisable to consume more green leafy vegetables, 
proteins and minerals in order to boost up immunity against dengue 
virus.  
• Patients are advised to avoid oily and spicy food. Because it may 
aggravate the patient condition. 
• Make sure window and door screens are secure and free of holes. 
It helps, as well, to get rid of places where mosquitoes may breed.  
• Regularly change the water in outdoor birdbaths and pets’ water 
dishes. 
• Prevention techniques can be pursued on preventing mosquito 
bites when traveling to areas where dengue occurs. Dengue might 
occur where there is low sanitation.  
Jeyamani et al. 
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• If someone in the home gets dengue fever, vigilant efforts should 
be exerted to protect other family members from mosquitoes.  
• When outdoors, wear long-sleeved shirts and long pants tucked 
into socks. When indoors, use air conditioning if available. Stay away 
from heavily populated residential areas.  
• Maintain good hygiene at home and environment, which are very 
essential. Cleanliness, a healthy immune system, and a proper diet 
will keep you away from dengue. 
• Make an effort to check whether the doors and windows are shut 
properly, especially during the evenings. Bed rest is recommended 
for symptomatic dengue fever. 
• Light camphor inside your home and apply neem oil all over your 
body to keep away mosquitoes [11-15].  
CONCLUSION 
Dengue fever most commonly affects young adults, mostly males. Hence, 
dengue fever does not have any particular medical remedy; the clinically 
improve the monitoring is broadly dependent on hematological 
complications. The only way to prevent us from dengue fever is 
preventing us from a mosquito bit. However, if caught early on, it is 
easier to prevent complications. The current case was planned to target 
on the counselling points for dengue, which made a better improvement 
in the patient and we take this measure as a community awareness 
outlook to spread alertness which can avoid the outbreak of Dengue. 
ACKNOWLEDGMENT 
The authors are thankful to Dr. C. Sekar, Chief Medical 
Superintendent, Government hospital, Thiruvallur for his constant 
support and encouragement throughout the study. We thank the 
patients who gave their willing consent for the publication of their 
case by sharing complete information needed for the study.  
COMPLIANCE WITH ETHICAL STANDARDS 
Written informed consent was obtained from the patient for 
publication of the case study, the inclusion of the accompanying 
images. Copies of written consent may be requested for review from 
the corresponding author. 
CONFLICT OF INTRESTS 
The authors declare no conflicts of interest concerning the content of 
this case report. 
REFERENCES 
1. Tamibmaniam J, Hussin N, Cheah WK. Proposal of a clinical 
decision tree algorithm using factors associated with severe 
dengue infection. PLoS ONE 2016;11:1-10. 
2. Medagoda K, Gunathilaka SB, De Silva HJ. A case of self-limiting 
coombs’ negative hemolytic anemia following dengue shock 
syndrome. Ceylon Med 2003;48:147–8. 
3. Verma R, Jatav VK, Sharma S. Identification of inhibitors of 
dengue virus (DENV1, DENV2 AND DENV3) NS2B/NS3 serine 
protease: a molicular docking and simulation approach. Asian J 
Pharm Clin Res 2015;8:287-92. 
4. Whitehorn J, Farrar J. Dengue. Br Med Bul 1995;95:161–73.  
5. Khan DM, Kuppusamy K, Sumathi S, Mrinalini VR. Evaluation 
of thrombocytopenia in dengue infection along with seasonal 
variation in rural melmaruvathur. J Clin Diagn Res 2014; 
8:39–42. 
6. Garg S, Arora R, Kakkar N. Fever and petechiae in a middle aged 
male. Labmedicine 2007;38:23-5.  
7. Tayade MR, Shinkar DM, Patil PB, Saudagar RB. Emerging 
therapy for dengue. Int J Curr Pharm Res 2018;10:1-4. 
8. Kulkarn D, Sharma B. Dengue fever-induced cold-agglutinin 
syndrome. Ther Adv Infect Dis 2014;2:97–9.  
9. Dutta D, Kuila P, Chatterjee D, Das S. Co-infection of brucella 
and dengue virus. Asian J Pharm Clin Res 2017;10:299-301. 
10. Aroor AR, Saya RP, Sharma A, Venkatesh A,  Alva R. Clinical 
manifestations and predictors of thrombocytopenia in 
hospitalized adults with dengue fever. N Am J Med Sci 
2015;7:547–52. 
11. Radakovic S, Graninger W, Müller C, Hönigsmann H, Tanew A. 
Dengue hemorrhagic fever in a British travel guide. J Am Acad 
Dermatol 2002;46:430–3.  
12. Liao B, Tang Y. Serum levels of soluble vascular cell adhesion 
molecules may correlate with the severity of dengue virus 
infection in adults. Emer Microbes Infect 2015;4:e24.  
13. Gupta MK, Shrivastava AK, Chauhan APS, Gaur DS, Mishra KK, 
Sharma S. Comparative study of the shiva guggulu and 
simhanada guggulu in the management of amavata 
(rheumatoid arthritis). Int J Appl Pharm 2016;8:5-12.  
14. Farista R, Muragundi PM. Practical possibilities to empower 
patients in the management of inflammatory bowel disease. J 
Crit Rev 2016;3:1-5.  
15. Harikesh Maurya H, Tirath Kumar T. A review on 
comprehensive overview in the management of nephrotic 
disorders. J Crit Rev 2016;3:34-43. 
 
